Proceedings of the Tenth International Conference of Drug Regulatory Authorities (ICDRA) - Hong Kong, China, 24 - 27 June 2002
(2002; 166 pages) Voir le document au format PDF
Table des matières
Afficher le documentAbbreviations and acronyms used in this report
Ouvrir ce répertoire et afficher son contenuOpening ceremony
Ouvrir ce répertoire et afficher son contenuHerbal medicines
Ouvrir ce répertoire et afficher son contenuKeynote address
Ouvrir ce répertoire et afficher son contenuSafety of blood-derived products
Ouvrir ce répertoire et afficher son contenuAntimicrobial resistance - new initiatives
Ouvrir ce répertoire et afficher son contenuHarmonization I
Ouvrir ce répertoire et afficher son contenuHarmonization II
Ouvrir ce répertoire et afficher son contenuProtection of trial subjects in clinical trials
Ouvrir ce répertoire et afficher son contenuRegulating biotechnology products
Ouvrir ce répertoire et afficher son contenuRegulatory challenges: health sector reform and drug regulatory capacity
Ouvrir ce répertoire et afficher son contenuAccess to drugs and vaccines I
Ouvrir ce répertoire et afficher son contenuAccess to drugs and vaccines II
Ouvrir ce répertoire et afficher son contenuCounterfeit pharmaceutical products
Fermer ce répertoireHomoeopathy
Afficher le documentRegistration criteria for homoeopathic medicinal products in the United Arab Emirates
Afficher le documentThe regulatory framework for homoeopathic medicinal products in Germany and in the European Union
Afficher le documentRegulation of homoeopathic products in the United Kingdom
Afficher le documentRecommendations
Ouvrir ce répertoire et afficher son contenuSafety monitoring
Ouvrir ce répertoire et afficher son contenuE-Commerce
Ouvrir ce répertoire et afficher son contenuCurrent topics
Ouvrir ce répertoire et afficher son contenuRegulatory challenges of new technologies
Afficher le documentList of participants
Afficher le documentBack cover
 

Registration criteria for homoeopathic medicinal products in the United Arab Emirates

Dr Sassan Behjat, United Arab Emirates

An increasing demand for homoeopathic treatment by the people of the United Arab Emirates (UAE) and a strong political will for regulation of complementary medicines have led to the establishment of a registration system for homoeopathic medicinal products under the Office of Complementary and Alternative Medicines of the Ministry of Health.

The objectives are to make available homoeopathic medicines within a legal framework that ensures consumer protection by guaranteeing that homoeopathic medicines imported into the UAE are of high quality, and that, for homoeopathic medicines sold directly to the public, adequate information is provided to allow informed decisions and to ensure safety of consumers.

Assessment is based on the safety and quality of the homoeopathic products. Manufacturers must be licensed and conform to GMP. Manufacturing processes should be in accordance with one of the internationally recognized pharmacopoeias. Restrictions are placed on advertisements, labelling and the dosage forms of the products. At the same time, homoeopathic practitioners are regulated and homoeopathic products can only be prescribed by licensed practitioners.

Continuing education of practitioners and pharmacists, and awareness programmes for the public, are of key importance.

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013